4.6 Review

Role of PFKFB3-driven glycolysis in sepsis

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

miR-193a-3p increases glycolysis under hypoxia by facilitating Akt phosphorylation and PFKFB3 activation in human macrophages

Dominik C. Fuhrmann et al.

Summary: Human macrophages undergoing hypoxia alter their metabolism, increasing glycolysis as an adaptation. MiR-193a-3p enhances Akt phosphorylation, which is regulated by PPTC7 protein abundance. This leads to increased glycolysis under hypoxia. MiR-193a-3p also affects PFKFB3 phosphorylation, further regulating glycolysis.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Article Cell Biology

IRF8 and BATF3 interaction enhances the cDC1 specific Pfkfb3 gene expression

Kuldeep Singh Chauhan et al.

Summary: Dendritic cells (DCs) are crucial in innate and adaptive immune responses. Different DC subtypes have distinct surface markers, transcriptional profiles, and functional responses. This study identified an interaction between IRF8 and BATF3, and an independent role of ID2 in cDC1 development. The study also discovered overlapping regions of occupancy by IRF8 and BATF3, and revealed the association of Pfkfb3 gene with the specific transcriptional pattern of cDC1 subtype. Additionally, the inhibition of PFKFB3 enzymatic activity affected cDC1 subtype in both in vitro and in vivo settings.

CELLULAR IMMUNOLOGY (2022)

Review Oncology

Nuances of PFKFB3 Signaling in Breast Cancer

Claudia Martins Galindo et al.

Summary: PFKFB3 is a critical enzyme that supports glucose catabolism and plays a role in the progression of various cancers. It is important for sustaining glycolysis in the tumor environment, promoting metabolic reprogramming, cell proliferation, DNA repair, and drug resistance. Breast cancer has unique characteristics that drive the expression of PFKFB3. This enzyme acts as a convergence point for multiple growth-promoting and oncogenic signaling pathways.

CLINICAL BREAST CANCER (2022)

Article Cell Biology

Syringaresinol Resisted Sepsis-Induced Acute Lung Injury by Suppressing Pyroptosis Via the Oestrogen Receptor-beta Signalling Pathway

Yuzhen Zhuo et al.

Summary: The study demonstrates that pretreatment with syringaresinol (SYR) can significantly reduce lung tissue damage induced by sepsis and alleviate lung tissue injury by inhibiting the production of inflammatory cytokines. SYR can effectively prevent CLP-induced pyroptosis in the lung by suppressing the activation of the NLRP3 inflammasome and downregulating related protein expression.

INFLAMMATION (2022)

Article Medicine, Research & Experimental

The role of macrophage-fibroblast interaction in lipopolysaccharide-induced pulmonary fibrosis: an acceleration in lung fibroblast aerobic glycolysis

Qiaoyi Xu et al.

Summary: The study demonstrates that lipopolysaccharide induces activation of the JNK signaling pathway and TNF-alpha secretion in pulmonary macrophages, leading to interaction between inflammation and metabolism that promotes lung fibroblast glycolysis. This interaction plays a crucial role in lipopolysaccharide-induced pulmonary fibrosis.

LABORATORY INVESTIGATION (2022)

Article Biotechnology & Applied Microbiology

Hyperglycemia induces miR-26-5p down-regulation to overexpress PFKFB3 and accelerate epithelial-mesenchymal transition in gastric cancer

Xiaobo He et al.

Summary: This study found that the overexpression of PFKFB3 is associated with poor prognosis in gastric cancer patients. Hyperglycemia stimulates the high expression of PFKFB3 and enhances proliferation, migration, and epithelial-mesenchymal transition in gastric cancer cells. Down-regulation of PFKFB3 by miR-26-5p inhibits the malignant phenotype of gastric cancer with hyperglycemia.

BIOENGINEERED (2022)

Article Peripheral Vascular Disease

PFKFB3 gene deletion in endothelial cells inhibits intraplaque angiogenesis and lesion formation in a murine model of venous bypass grafting

Paola Perrotta et al.

Summary: The study shows that deletion of the PFKFB3 gene in ECs can significantly reduce the size of vein graft lesions, IP angiogenesis and hemorrhages, without obvious adverse effects or changes in general metabolism. Additionally, RT-PCR results indicate an increased M2 macrophage signature in vein grafts from mice with EC-specific PFKFB3 deletion.

ANGIOGENESIS (2022)

Article Cardiac & Cardiovascular Systems

Cholesterol crystals drive metabolic reprogramming and M1 macrophage polarisation in primary human macrophages

Sinead A. O'Rourke et al.

Summary: This study provides further insights into how atherosclerosis-associated molecules affect immune cell function and highlights metabolic reprogramming as a potential therapeutic target for cholesterol crystal-related inflammation.

ATHEROSCLEROSIS (2022)

Article Allergy

M1 Macrophages Increase Endothelial Permeability and Enhance p38 Phosphorylation via PPAR-γ/CXCL13-CXCR5 in Sepsis

Wen Chen et al.

Summary: This study investigates the relationship between M1 macrophages and HUVECs, as well as the underlying molecular mechanisms. The results show that M1 macrophages induce endothelial hyperpermeability and promote p38 phosphorylation in sepsis by inhibiting PPAR-gamma to increase CXCL13 production. PPAR-gamma/CXCL13-CXCR5 signaling could be a promising novel therapeutic target for sepsis.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

Comparison of Macrophage Immune Responses and Metabolic Reprogramming in Smooth and Rough Variant Infections of Mycobacterium mucogenicum

Minji Kang et al.

Summary: In this study, it was found that the rough type of Mycobacterium mucogenicum is more virulent than the smooth type, induces a stronger immune response, and leads to more extensive metabolic reprogramming. The findings provide a fundamental basis for further research on Mmuc pathogenesis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Immunology

Berberine Modulates Macrophage Activation by Inducing Glycolysis

Min Li et al.

Summary: Berberine induces aerobic glycolysis by blocking the tricarboxylic acid cycle and modulates cytokine responses in macrophages. It affects the expression of glucose transporter and cellular hexokinase, thereby influencing cytokine secretion.

JOURNAL OF IMMUNOLOGY (2022)

Article Cell Biology

IGFBP5 promotes diabetic kidney disease progression by enhancing PFKFB3-mediated endothelial glycolysis

Chengcheng Song et al.

Summary: Renal inflammation is a critical characteristic of diabetic kidney disease (DKD), but effective treatments are limited. This study found that insulin-like growth factor-binding protein 5 (IGFBP5) is significantly increased in the kidneys of diabetic mice. Elimination of IGFBP5 alleviated kidney inflammation in DKD mice. Mechanistically, IGFBP5 increased glycolysis in endothelial cells through the activation of the transcription factor EGR1 and enhanced expression of PFKFB3, which in turn enhanced renal inflammation.

CELL DEATH & DISEASE (2022)

Article Immunology

Apelin-13 Attenuates Lipopolysaccharide-Induced Inflammatory Responses and Acute Lung Injury by Regulating PFKFB3-Driven Glycolysis Induced by NOX4-Dependent ROS

Yafei Yuan et al.

Summary: Apelin-13 protects against LPS-induced inflammatory responses and ALI by regulating PFKFB3-driven glycolysis induced by NOX4-dependent ROS.

JOURNAL OF INFLAMMATION RESEARCH (2022)

Review Medicine, Research & Experimental

The role of itaconate in host defense and inflammation

Christian G. Peace et al.

Summary: Inflammatory stimuli cause metabolic reprogramming in macrophages, particularly in the Krebs cycle, resulting in the accumulation of itaconate and other metabolites. Itaconate plays diverse roles in immunity and inflammation, including inhibiting inflammasome activation and glycolysis, activating anti-inflammatory transcription factors, and exerting anti-inflammatory effects in various disease models.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Article Peripheral Vascular Disease

YAP promotes ocular neovascularization by modifying PFKFB3-driven endothelial glycolysis

Yifan Feng et al.

Summary: The study demonstrated that YAP plays a crucial role in promoting glycolysis, proliferation, migration, and tube formation of HUVECs under hypoxia by regulating PFKFB3 expression. Silencing of YAP reversed these effects and intravitreal injection of small interfering RNA targeting YAP or PFKFB3 significantly suppressed neovascular growth in mouse models.

ANGIOGENESIS (2021)

Article Medicine, Research & Experimental

Adipose tissue inflammation and systemic insulin resistance in mice with diet-induced obesity is possibly associated with disruption of PFKFB3 in hematopoietic cells

Bilian Zhu et al.

Summary: The disruption of PFKFB3 in hematopoietic cells exacerbates HFD-induced white adipose tissue inflammation and systemic insulin resistance.

LABORATORY INVESTIGATION (2021)

Article Critical Care Medicine

Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021

Laura Evans et al.

INTENSIVE CARE MEDICINE (2021)

Article Medicine, Research & Experimental

MALAT1 sponges miR-26a and miR-26b to regulate endothelial cell angiogenesis via PFKFB3-driven glycolysis in early-onset preeclampsia

Qi Li et al.

Summary: In early-onset preeclampsia (EOPE), decreased expression of MALAT1 and PFKFB3 is associated with endothelial cell dysfunction. PFKFB3 modulates the proliferation, migration, and tube formation of ECs by regulating glycolysis, while MALAT1 regulates PFKFB3 expression by sponging miR-26a/26b. MALAT1 knockdown reduces EC angiogenesis by inhibiting PFKFB3-mediated glycolysis flux, suggesting that strategies targeting PFKFB3-driven glycolysis may be a promising approach for EOPE treatment.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Review Pharmacology & Pharmacy

Extracellular vesicle activities regulating macrophage- and tissue-mediated injury and repair responses

Qian Hu et al.

Summary: Recent studies have shown the importance of extracellular vesicles (EVs) in mediating interactions between macrophages and tissue cells, influencing tissue inflammation, injury, and repair processes. The release of EVs can affect the activation and polarization of macrophages, leading to various inflammatory disease conditions.

ACTA PHARMACEUTICA SINICA B (2021)

Review Oncology

Metabolic Reprogramming of Fibroblasts as Therapeutic Target in Rheumatoid Arthritis and Cancer: Deciphering Key Mechanisms Using Computational Systems Biology Approaches

Sahar Aghakhani et al.

Summary: Fibroblasts are crucial regulators in the extracellular matrix regulation, capable of synthesizing various ECM proteins. Under certain stimuli, they can transform into aggressive phenotypes contributing to disease pathophysiology. Metabolic reprogramming is identified as a critical event in the transition of fibroblasts from inactive to activated and aggressive cells, particularly in rheumatoid arthritis and cancer, presenting new potential therapeutic targets and strategies.

CANCERS (2021)

Review Oncology

Metabolic reprogramming in macrophage responses

Yang Liu et al.

Summary: Macrophages are key regulators of tissue homeostasis, involved in tissue development, repair, and defense against pathogens. TAMs play a crucial role in the tumor microenvironment, impacting tumor initiation, growth, invasion, and metastasis. The metabolic characteristics of macrophages influence their phenotype and function, with pro-inflammatory M1 macrophages relying on glycolysis and anti-inflammatory M2 macrophages more dependent on mitochondrial OXPHOS.

BIOMARKER RESEARCH (2021)

Editorial Material Immunology

Dissolving the cytosolic bacteria in non-immune cells

Fengjiao Lu et al.

Summary: Apolipoprotein L3 (APOL3), induced by IFN-gamma, is identified as a crucial host factor targeting and killing intracellular bacteria, revealing a new IFN-gamma-dependent innate defense mechanism in non immune cells through a genome-wide CRISPR-Cas9 screen conducted by Gaudet et al.

TRENDS IN IMMUNOLOGY (2021)

Review Oncology

Role of PFKFB3 and PFKFB4 in Cancer: Genetic Basis, Impact on Disease Development/Progression, and Potential as Therapeutic Targets

Krzysztof Kotowski et al.

Summary: Glycolysis is a crucial metabolic process in rapidly proliferating cells, such as cancer cells, with PFK-1 being a key rate-limiting enzyme regulated primarily by F-2,6-BP. PFK-2/FBPase-2 is a bifunctional enzyme responsible for F-2,6-BP synthesis and degradation, and alterations in PFKFB isozymes play important roles in various diseases, particularly in cancer.

CANCERS (2021)

Review Biochemistry & Molecular Biology

Two Faces of Macrophages: Training and Tolerance

Kiran Zubair et al.

Summary: Macrophages play crucial roles in host defense, wound healing, tissue regeneration, but also contribute to the development of various diseases such as cancers and autoimmune disorders. Studies have focused on understanding the molecular mechanisms of macrophage training and tolerance in inflammatory diseases.

BIOMEDICINES (2021)

Article Cardiac & Cardiovascular Systems

Glycolysis Inhibition Alleviates Cardiac Fibrosis After Myocardial Infarction by Suppressing Cardiac Fibroblast Activation

Zhi-Teng Chen et al.

Summary: The study demonstrated the significant role of glycolysis in cardiac fibrosis post-myocardial infarction, with glycolysis inhibition showing potential in reducing cardiac fibroblast activation and fibrosis.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Deficiency of Myeloid Pfkfb3 Protects Mice From Lung Edema and Cardiac Dysfunction in LPS-Induced Endotoxemia

Jiean Xu et al.

Summary: The study reveals the critical role of Pfkfb3 in LPS-induced sepsis, showing that its knockout protects mice from severe effects and reduces inflammation by regulating the expression of inflammatory factors.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Medicine, Research & Experimental

Metformin prevents PFKFB3-related aerobic glycolysis from enhancing collagen synthesis in lung fibroblasts by regulating AMPK/mTOR pathway

Ci-Jun Tang et al.

Summary: The study demonstrated that metformin may prevent PFKFB3-associated aerobic glycolysis from enhancing collagen synthesis in lung fibroblasts by regulating the AMPK/mTOR pathway.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)

Article Biochemistry & Molecular Biology

Inflammatory activation of endothelial cells increases glycolysis and oxygen consumption despite inhibiting cell proliferation

Jonas Aakre Wik et al.

Summary: The study shows that inflammatory activation of human umbilical vein endothelial cells by interleukin-1 beta promotes a shift towards a more metabolically active phenotype, driven by shunting of glucose-derived pyruvate into mitochondria. The metabolic response to IL-1 beta varies significantly among donors, highlighting the importance of considering donor-specific responses when targeting dysregulated endothelial cell metabolism.

FEBS OPEN BIO (2021)

Article Chemistry, Medicinal

Cynaroside prevents macrophage polarization into pro-inflammatory phenotype and alleviates cecal ligation and puncture-induced liver injury by targeting PKM2/HIF-1α axis

Liuhua Pei et al.

Summary: The study revealed that cynaroside can promote phenotypic transition of hepatic macrophages from M1 to M2, alleviating sepsis-induced liver inflammation. Results suggest that cynaroside has a novel role in modulating immunometabolic pathways through affecting pyruvate kinase M2-mediated glycolysis, which could be valuable in sepsis treatment.

FITOTERAPIA (2021)

Review Immunology

The roles of macrophage polarization in the host immune response to sepsis

Xinsen Chen et al.

Summary: Sepsis is a life-threatening clinical syndrome caused by infection, resulting in immune imbalance. Research has found that macrophage polarization plays a crucial role in the pathogenesis of sepsis, with an imbalance causing inflammation and dysregulation of anti-inflammatory responses.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

The PFKFB3 Inhibitor AZ67 Inhibits Angiogenesis Independently of Glycolysis Inhibition

Besa Emini Veseli et al.

Summary: The study aimed to investigate the effects of PFKFB3 inhibition on angiogenesis using the small molecule AZ67. It was found that AZ67 could disrupt angiogenesis independently of glycolysis inhibition, even though it did not significantly affect certain aspects of cellular metabolism.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Endocrinology & Metabolism

The Role of HIF1α-PFKFB3 Pathway in Diabetic Retinopathy

Jie Min et al.

Summary: Diabetic retinopathy is the leading cause of blindness in developed countries, with neuronal impairment often preceding microvascular abnormalities. Current therapeutic strategies fail to target neuronal deterioration, necessitating new approaches to address both vascular and neuronal impairment. The HIF1α-PFKFB3 signaling pathway plays a critical role in neurodegeneration and pathologic angiogenesis in DR, highlighting its potential as a metabolic intervention point.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Pharmacology & Pharmacy

In vitro angiogenesis inhibition with selective compounds targeting the key glycolytic enzyme PFKFB3

Anahita Abdali et al.

Summary: Abnormal glycolytic metabolism contributes to angiogenic sprouting in atherogenesis. Specific PFKFB3 inhibitors demonstrated anti-angiogenic properties in endothelial cells by reducing migration, proliferation, and angiogenic sprout formation. Targeting PFKFB3 could be a potential therapeutic strategy for cancer or other pathologies where angiogenesis plays a detrimental role.

PHARMACOLOGICAL RESEARCH (2021)

Article Microbiology

Genetic Variation in PFKFB3 Impairs Antifungal Immunometabolic Responses and Predisposes to Invasive Pulmonary Aspergillosis

Samuel M. Goncalves et al.

Summary: Genetic variation in the PFKFB3 gene has been associated with increased risk of invasive pulmonary aspergillosis (IPA) after allogeneic hematopoietic stem cell transplantation, impairing the antifungal effector functions of macrophages and leading to lower cytokine concentrations in IPA patients. These findings support the inclusion of PFKFB3 in prognostic tools for predicting the risk of fungal infection in this clinical setting.
Article Pharmacology & Pharmacy

Anlotinib Inhibits PFKFB3-Driven Glycolysis in Myofibroblasts to Reverse Pulmonary Fibrosis

Weimou Chen et al.

Summary: Our study demonstrates that anlotinib has antifibrotic effects by inhibiting myofibroblast activation and glycolysis. We also reveal a novel mechanism involving PCBP3 in regulating glycolysis reprogramming during lung fibrogenesis, suggesting it as a potential therapeutic target for pulmonary fibrosis. Anlotinib shows promise as a potent candidate for treating pulmonary fibrosis due to its preventative and therapeutic effects observed in animal models.

FRONTIERS IN PHARMACOLOGY (2021)

Editorial Material Immunology

Editorial: Regulation of Immunity by Non-Immune Cells

Teruki Dainichi et al.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Glycolysis Inhibition Induces Functional and Metabolic Exhaustion of CD4+ T Cells in Type 1 Diabetes

Christina P. Martins et al.

Summary: In T1D, CD4(+) T cells can be targeted and their metabolic reprogramming altered by using the small molecule PFK15 as a competitive inhibitor. This approach delayed diabetes onset in animal models, with a significant percentage of animals maintaining normal blood glucose levels. The results demonstrate a novel therapeutic strategy to control aberrant T cell responses by exploiting metabolic reprogramming in T1D.

FRONTIERS IN IMMUNOLOGY (2021)

Review Medicine, General & Internal

Metabolic Alterations in Sepsis

Weronika Wasyluk et al.

Summary: Sepsis is a potentially life-threatening condition characterized by organ dysfunction caused by a dysregulated host response to infection. Metabolic disturbances, including changes in carbohydrate, lipid, ketone body, and amino acid metabolism, are common in septic patients and may serve as a target for potential future therapies.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Endocrinology & Metabolism

The Role of HIF1 alpha-PFKFB3 Pathway in Diabetic Retinopathy

Jie Min et al.

Summary: Diabetic retinopathy (DR) is the leading cause of blindness for adults in developed countries, with microvasculopathy and neurodegeneration implicated in its development. Current therapeutic strategies mainly target the advanced stages and fail to address neuronal deterioration, highlighting the potential need for new approaches. The HIF1 alpha-PFKFB3 signaling pathway is identified as a key component across multiple cell types in the retina in both early and late stages of DR, suggesting its potential as a therapeutic target.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Review Biochemistry & Molecular Biology

Neutrophil Metabolic Shift during Their Lifecycle: Impact on Their Survival and Activation

Louise Injarabian et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

Glycolysis - a key player in the inflammatory response

Gonzalo Soto-Heredero et al.

FEBS JOURNAL (2020)

Article Immunology

Zhx2 Accelerates Sepsis by Promoting Macrophage Glycolysis via Pfkfb3

Zehua Wang et al.

JOURNAL OF IMMUNOLOGY (2020)

Article Cell Biology

c-Src Promotes Tumorigenesis and Tumor Progression by Activating PFKFB3

Huanhuan Ma et al.

CELL REPORTS (2020)

Review Medicine, General & Internal

The cellular basis of organ failure in sepsis-signaling during damage and repair processes

M. Bauer et al.

MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN (2020)

Review Pharmacology & Pharmacy

Macrophage M1/M2 polarization

Chen Yunna et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2020)

Review Biochemistry & Molecular Biology

Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis

Marta Bueno et al.

REDOX BIOLOGY (2020)

Review Immunology

Contribution of Non-immune Cells to Activation and Modulation of the Intestinal Inflammation

Renata Curciarello et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Pharmacology & Pharmacy

Ablation of endothelial Pfkfb3 protects mice from acute lung injury in LPS-induced endotoxemia

Lina Wang et al.

PHARMACOLOGICAL RESEARCH (2019)

Review Immunology

Metabolic Insight of Neutrophils in Health and Disease

Sachin Kumar et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Medicine, General & Internal

Metabolic Reprogramming as a Driver of Fibroblast Activation in Pulmonary Fibrosis

Rachel Para et al.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2019)

Review Immunology

Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis

Eleni Karakike et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Multidisciplinary Sciences

The NLRP3 inflammasome modulates glycolysis by increasing PFKFB3 in an IL-1β-dependent manner in macrophages

Orla M. Finucane et al.

SCIENTIFIC REPORTS (2019)

Review Medicine, Research & Experimental

Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last?

Lise Van Wyngene et al.

EMBO MOLECULAR MEDICINE (2018)

Review Pharmacology & Pharmacy

The potential utility of PFKFB3 as a therapeutic target

Ramon Bartrons et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2018)

Article Cell Biology

Metabolic control of cell fate bifurcations in a hematopoietic progenitor population

Radomir Kratchmarov et al.

IMMUNOLOGY AND CELL BIOLOGY (2018)

Review Physiology

ENDOTHELIAL CELL METABOLISM

Guy Eelen et al.

PHYSIOLOGICAL REVIEWS (2018)

Article Multidisciplinary Sciences

Neutrophil extracellular trap formation requires OPA1-dependent glycolytic ATP production

Poorya Amini et al.

NATURE COMMUNICATIONS (2018)

Review Cardiac & Cardiovascular Systems

Endothelial biomarkers in human sepsis: pathogenesis and prognosis for ARDS

Carolyn M. Hendrickson et al.

PULMONARY CIRCULATION (2018)

Review Cell Biology

Neutrophil dysregulation during sepsis: an overview and update

Xiao-Fei Shen et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)

Article Oncology

Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma

Hui-Min Li et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)

Article Dermatology

PFKFB3, a Direct Target of p63, Is Required for Proliferation and Inhibits Differentiation in Epidermal Keratinocytes

Robert B. Hamanaka et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)

Article Cell Biology

Myeloid-derived suppressor cellsa new therapeutic target to overcome resistance to cancer immunotherapy

Jason A. Chesney et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2017)

Review Biochemistry & Molecular Biology

Mitochondria as Molecular Platforms Integrating Multiple Innate Immune Signalings

Marie Monlun et al.

JOURNAL OF MOLECULAR BIOLOGY (2017)

Review Biochemistry & Molecular Biology

Roles of PFKFB3 in cancer

Linlin Shi et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)

Review Cell Biology

Ancillary Activity: Beyond Core Metabolism in Immune Cells

Daniel J. Puleston et al.

CELL METABOLISM (2017)

Article Medicine, General & Internal

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

Mervyn Singer et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Article Biochemical Research Methods

Metabolic Profiling Regarding Pathogenesis of Idiopathic Pulmonary Fibrosis

Yun Pyo Kang et al.

JOURNAL OF PROTEOME RESEARCH (2016)

Article Critical Care Medicine

Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis

Na Xie et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)

Article Biochemistry & Molecular Biology

Overexpression of miR-206 suppresses glycolysis, proliferation and migration in breast cancer cells via PFKFB3 targeting

Xin Ge et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Article Immunology

Metabolic requirements for neutrophil extracellular traps formation

Oscar Rodriguez-Espinosa et al.

IMMUNOLOGY (2015)

Editorial Material Critical Care Medicine

Understanding ARDS-associated fibroproliferation

Gianfranco Umberto Meduri et al.

INTENSIVE CARE MEDICINE (2015)

Article Critical Care Medicine

Evaluation of endothelial damage in sepsis-related ARDS using circulating endothelial cells

Mouhamed Djahoum Moussa et al.

INTENSIVE CARE MEDICINE (2015)

Article Biochemistry & Molecular Biology

Acute Lung Injury and Fibrosis in a Baboon Model of Escherichia coli Sepsis

Ravi S. Keshari et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2014)

Editorial Material Cell Biology

The glycolytic enzyme PFKFB3/phosphofructokinase regulates autophagy

Zhen Yang et al.

AUTOPHAGY (2014)

Article Biochemistry & Molecular Biology

Mitochondria Regulate Neutrophil Activation by Generating ATP for Autocrine Purinergic Signaling

Yi Bao et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Cell Biology

SIRT1 inhibition during the hypoinflammatory phenotype of sepsis enhances immunity and improves outcome

Vidula T. Vachharajani et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2014)

Article Biochemistry & Molecular Biology

PFKFB3 Regulates Oxidative Stress Homeostasis via Its S-Glutathionylation in Cancer

Minsuh Seo et al.

JOURNAL OF MOLECULAR BIOLOGY (2014)

Article Biochemistry & Molecular Biology

PFKFB3 activation in cancer cells by the p38/MK2 pathway in response to stress stimuli

Laura Novellasdemunt et al.

BIOCHEMICAL JOURNAL (2013)

Article Biochemistry & Molecular Biology

Role of PFKFB3-Driven Glycolysis in Vessel Sprouting

Katrien De Bock et al.

Editorial Material Critical Care Medicine

Endothelial injury in sepsis

Marcel Levi et al.

INTENSIVE CARE MEDICINE (2013)

Review Immunology

Neutrophil recruitment and function in health and inflammation

Elzbieta Kolaczkowska et al.

NATURE REVIEWS IMMUNOLOGY (2013)

Article Biochemistry & Molecular Biology

Excitotoxic stimulus stabilizes PFKFB3 causing pentose-phosphate pathway to glycolysis switch and neurodegeneration

P. Rodriguez-Rodriguez et al.

CELL DEATH AND DIFFERENTIATION (2012)

Article Medicine, Research & Experimental

PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice

Mei Tran et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Article Cardiac & Cardiovascular Systems

Hyperlipidemia-Triggered Neutrophilia Promotes Early Atherosclerosis

Maik Drechsler et al.

CIRCULATION (2010)

Article Allergy

Overview of the immune response

David D. Chaplin

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)

Article Immunology

Substrate Fate in Activated Macrophages: A Comparison between Innate, Classic, and Alternative Activation

Juan-Carlos Rodriguez-Prados et al.

JOURNAL OF IMMUNOLOGY (2010)

Article Multidisciplinary Sciences

Anaphase-promoting complex/cyclosome-Cdh1 coordinates glycolysis and glutaminolysis with transition to S phase in human T lymphocytes

Sergio L. Colombo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Critical Care Medicine

Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock

Mark E. Mikkelsen et al.

CRITICAL CARE MEDICINE (2009)

Review Immunology

Pulmonary fibrosis: pathogenesis, etiology and regulation

M. S. Wilson et al.

MUCOSAL IMMUNOLOGY (2009)

Article Hematology

Mitochondria in neutrophil apoptosis

B. J. van Raam et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2006)

Article Critical Care Medicine

Monocytes/macrophages and sepsis

JM Cavaillon et al.

CRITICAL CARE MEDICINE (2005)

Article Biochemistry & Molecular Biology

Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis

NA Maianski et al.

CELL DEATH AND DIFFERENTIATION (2004)

Article Anesthesiology

Physiology of the endothelium

HF Galley et al.

BRITISH JOURNAL OF ANAESTHESIA (2004)

Review Biochemistry & Molecular Biology

PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2, 6-bisphosphate

DO Okar et al.

TRENDS IN BIOCHEMICAL SCIENCES (2001)

Article Physiology

Hypoxia induces hexokinase II gene expression in human lung cell line A549

SR Riddle et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2000)